Mangoceuticals, Inc.
MGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $616 | $731 | $9 | $0 |
| % Growth | -15.8% | 8,083.2% | – | – |
| Cost of Goods Sold | $236 | $300 | $4 | $0 |
| Gross Profit | $380 | $432 | $5 | $0 |
| % Margin | 61.7% | 59% | 54.3% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6,420 | $3,319 | $1,644 | $0 |
| SG&A Expenses | $7,898 | $5,417 | $1,996 | $18 |
| Sales & Mktg Exp. | $1,479 | $2,098 | $353 | $0 |
| Other Operating Expenses | $454 | $4,233 | $0 | $0 |
| Operating Expenses | $8,352 | $9,650 | $1,996 | $18 |
| Operating Income | -$7,972 | -$9,219 | -$1,992 | -$18 |
| % Margin | -1,294.4% | -1,260.3% | -22,279.7% | – |
| Other Income/Exp. Net | -$735 | $6 | -$6 | -$0 |
| Pre-Tax Income | -$8,707 | -$9,212 | -$1,998 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,706 | -$9,212 | -$1,998 | -$18 |
| % Margin | -1,413.6% | -1,259.4% | -22,352.1% | – |
| EPS | -4.399 | -8.58 | -1.731 | -0.018 |
| % Growth | 48.7% | -395.7% | -9,679.1% | – |
| EPS Diluted | -4.399 | -8.58 | -1.731 | -0.018 |
| Weighted Avg Shares Out | 1,979 | 1,074 | 1,154 | 998 |
| Weighted Avg Shares Out Dil | 1,979 | 1,074 | 1,154 | 998 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $0 | $6 | $0 |
| Depreciation & Amortization | $722 | $25 | $4 | $0 |
| EBITDA | -$7,962 | -$8,094 | -$1,988 | -$18 |
| % Margin | -1,292.8% | -1,106.4% | -22,236.5% | – |